| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -40.73M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, CAPR returned -11.4% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -78.2% |
| 1 year | -11.4% |
| 5 years | +25.5% |
| 10 years | -82.8% |
| All-time high | $2,875.00 (Nov 2007) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in CAPR would be worth today ›No. Capricor Therapeutics, Inc. has not paid a dividend in the past 12 months.
Capricor Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol CAPR.
Capricor Therapeutics, Inc. is part of the Healthcare sector.
Capricor Therapeutics, Inc. has a market cap of 365.69M USD, based on the latest quote.
Capricor Therapeutics, Inc. is scheduled to report earnings on Nov 10, 2026.
